Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Devillier, Raynier
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Rey G
,
Daguenet E
,
Bonjean P
,
Devillier R
,
Fegueux N
,
Forcade E
,
Srour M
,
Chevallier P
,
Robin M
,
Suarez F
, et al.
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC.
Bone Marrow Transplant. 2023.
PubMed
Google Scholar
B
Lacan C
,
Lambert J
,
Forcade E
,
Robin M
,
Chevallier P
,
Loron S
,
Bulabois C-E
,
Orvain C
,
Ceballos P
,
Daguindau E
, et al.
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
J Hematol Oncol. 2024;17(1):2.
PubMed
Google Scholar
C
De Philippis C
,
Legrand-Izadifar F
,
Bramanti S
,
Giordano L
,
de Oca CMontes
,
Duléry R
,
Bouabdallah R
,
Granata A
,
Devillier R
,
Mariotti J
, et al.
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma.
Blood Adv. 2020;4(7):1242-1249.
PubMed
Google Scholar
Devillier R
,
Raffoux E
,
Rey J
,
Lengline E
,
Ronchetti A-M
,
Sebert M
,
Boissel N
,
Robin M
,
Vey N
,
Kiladjian J-J
, et al.
Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms.
Br J Haematol. 2015.
PubMed
Google Scholar
Santoro N
,
Mooyaart JE
,
Devillier R
,
Koc Y
,
Vydra J
,
Castagna L
,
Gulbas Z
,
Martin JDiez
,
Araujo MColorado
,
Kulagin A
, et al.
Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party.
Bone Marrow Transplant. 2022.
PubMed
Google Scholar
G
Devillier R
,
Eikema D-J
,
Dufour C
,
Aljurf M
,
Wu D
,
Maschan A
,
Kulagin A
,
Halkes CJM
,
Collin M
,
Snowden J
, et al.
Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT.
Haematologica. 2023.
PubMed
Google Scholar
H
Blaise D
,
Furst S
,
Crocchiolo R
,
El-Cheikh J
,
Granata A
,
Harbi S
,
Bouabdallah R
,
Devillier R
,
Bramanti S
,
Lemarie C
, et al.
Haploidentical T-cell replete transplantation with post-transplant cyclophosphamide for patients in or above the 6(th) decade of age compared with allogeneic hematopoietic stem cell transplantation from an HLA-matched related or unrelated donor.
Biol Blood Marrow Transplant. 2015.
PubMed
Google Scholar
I
Mariotti J
,
Raiola AMaria
,
Evangelista A
,
Harbi S
,
Patriarca F
,
Carella MAngelo
,
Martino M
,
Risitano A
,
Busca A
,
Giaccone L
, et al.
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide.
Bone Marrow Transplant. 2022.
PubMed
Google Scholar
P
Cauchois R
,
Castagna L
,
Pagliardini T
,
Harbi S
,
Calmels B
,
Bramanti S
,
Granata A
,
Lemarie C
,
Maisano V
,
Legrand F
, et al.
Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3 cells.
Br J Haematol. 2018.
PubMed
Google Scholar
R
Devillier R
,
Galimard J-E
,
Labopin M
,
Blaise D
,
Raiola AMaria
,
Pavlu J
,
Castagna L
,
Socié G
,
Chalandon Y
,
Martino M
, et al.
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT.
Bone Marrow Transplant. 2022.
PubMed
Google Scholar
Duléry R
,
Goudet C
,
Mannina D
,
Bianchessi A
,
Granata A
,
Harbi S
,
Maisano V
,
Chabannon C
,
Malard F
,
Brissot E
, et al.
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies.
Bone Marrow Transplant. 2022.
PubMed
Google Scholar